Table 2.
relationship types | entities modified by |
||
---|---|---|---|
genes | drugs | phenotypes | |
2538 associate | 1237 gene | 267 metabolism | 304 cell |
1017 increase | 1000 inhibitor | 229 activity | 114 line |
985 inhibit | 935 polymorphism | 226 administration | 101 patient |
825 induce | 775 expression | 213 treatment | 71 risk |
763 metabolize | 773 activity | 207 effect | 35 tissue |
666 involve | 689 mutation | 205 inhibitor | 34 specimen |
643 reduce | 685 genotype | 146 dose | 33 case |
547 catalyze | 393 inhibition | 137 concentration | 27 treatment |
515 cause | 329 level | 104 level | 26 rate |
509 affect | 245 gene_mutation | 103 substrate | 26 effect |
490 decrease | 232 gene_polymorphism | 90 clearance | 26 breast=cancer |
433 show | 227 allele | 88 antagonist | 22 incidence |
428 express | 162 variant | 84 channel | 21 factor |
392 relate | 156 enzyme | 75 inhibition | 21 resistance |
392 use | 138 mrna | 73 responsible | 20 sample |
387 correlate | 125 protein | 72 hydroxylation | 18 model |
385 influence | 83 channel | 70 enzyme | 16 exposure |
355 determine | 81 isoform | 67 oxidation | 15 type |
354 contribute | 78 effect | 65 gene | 15 development |
319 factor | 77 isozyme | 63 formation | 15 group |
318 mediate | 76 cell | 62 blocker | 14 % |
317 had | 73 deficiency | 60 metabolite | 14 activity |
301 found | 71 overexpression | 57 dependent | 14 mellitus |
299 measure | 67 substrate | 52 exposure | 13 gene |
287 investigate | 67 induction | 46 ratio | 13 cause |
284 result | 63 gene_expression | 45 consumption | 13 presence |
281 studied | 59 c677t | 44 due | 13 all |
280 detect | 58 inhibitor_use | 43 drug | 13 level |
274 association | 57 gene_allele | 40 response | 12 severity |
274 have | 55 content | 38 bioavailability | 12 study |